These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

261 related items for PubMed ID: 8947953

  • 61. Platelet activating factor antagonist enhances lung preservation in a canine model of single lung allotransplantation.
    Corcoran PC, Wang Y, Katz NM, Rajan SS, Analouei AR, Foegh ML, Wallace RB.
    J Thorac Cardiovasc Surg; 1992 Jul; 104(1):66-72. PubMed ID: 1614217
    [Abstract] [Full Text] [Related]

  • 62. Posttreatment but not pretreatment with selective beta-adrenoreceptor 1 antagonists provides neuroprotection in the hippocampus in rats subjected to transient forebrain ischemia.
    Iwata M, Inoue S, Kawaguchi M, Nakamura M, Konishi N, Furuya H.
    Anesth Analg; 2010 Apr 01; 110(4):1126-32. PubMed ID: 20357154
    [Abstract] [Full Text] [Related]

  • 63. Lack of platelet-activating factor release on acute myocardial ischemia in the isolated interventricular septum of rabbit heart.
    Salinas P, Perez MD, Fernandez-Sanpablo R, Fernandez-Gallardo S, Sanchez-Crespo M, Barrigón S.
    Eur J Pharmacol; 1995 May 26; 293(1):65-70. PubMed ID: 7672009
    [Abstract] [Full Text] [Related]

  • 64. [Effects of Ginkgo biloba extract against excitotoxicity induced by NMDA receptors and mechanism thereof].
    Xiao ZY, Sun CK, Xiao XW, Lin YZ, Li S, Ma H, Song GR, Cheng R.
    Zhonghua Yi Xue Za Zhi; 2006 Sep 19; 86(35):2479-84. PubMed ID: 17156678
    [Abstract] [Full Text] [Related]

  • 65. Pooling of blood in postischemic shock is modulated by platelet-activating factor (PAF).
    Sagach VF, Dmitrieva AV, Braquet P.
    Lipids; 1991 Dec 19; 26(12):1400-3. PubMed ID: 1819740
    [Abstract] [Full Text] [Related]

  • 66. The effect of L-carnitine on platelet activating factor concentration in the immature rat model of hypoxic-ischemic brain injury.
    Akisü M, Kültürsay N, Coker I, Hüseyinov A.
    Acta Med Okayama; 1998 Aug 19; 52(4):183-7. PubMed ID: 9781268
    [Abstract] [Full Text] [Related]

  • 67. Bleomycin-induced lung injury in the rat: effects of the platelet-activating factor (PAF) receptor antagonist BN 52021 and platelet depletion.
    Evans TW, McAnulty RJ, Rogers DF, Chung KF, Barnes PJ, Laurent GJ.
    Environ Health Perspect; 1990 Apr 19; 85():65-9. PubMed ID: 1696541
    [Abstract] [Full Text] [Related]

  • 68. Protective effect of a specific platelet-activating factor antagonist, BN 52021, on bupivacaine-induced cardiovascular impairments in rats.
    Lagente V, Simonetti MP, Fortes ZB, Braquet P.
    Pharmacol Res; 1989 Apr 19; 21(5):577-85. PubMed ID: 2594614
    [Abstract] [Full Text] [Related]

  • 69. Effects of the specific platelet-activating factor antagonists, BN 52021 and BN 52063, on various experimental gastrointestinal ulcerations.
    Braquet P, Etienne A, Mencia-Huerta JM, Clostre F.
    Eur J Pharmacol; 1988 Jun 10; 150(3):269-76. PubMed ID: 3046952
    [Abstract] [Full Text] [Related]

  • 70. Endothelium-dependent vasodilation in the isolated rabbit kidney following in vivo and in vitro ischaemia and reperfusion: effects of antagonizing platelet activating factor (PAF).
    Uluoglu C, Timlioglu O.
    Naunyn Schmiedebergs Arch Pharmacol; 1999 Sep 10; 360(3):324-30. PubMed ID: 10543435
    [Abstract] [Full Text] [Related]

  • 71. Effect of ketamine on hypoxic-ischemic brain damage in newborn rats.
    Spandou E, Karkavelas G, Soubasi V, Avgovstides-Savvopoulou P, Loizidis T, Guiba-Tziampiri O.
    Brain Res; 1999 Feb 20; 819(1-2):1-7. PubMed ID: 10082854
    [Abstract] [Full Text] [Related]

  • 72. Evidence against a role for platelet-activating factor in hypoxic pulmonary vasoconstriction in the rat.
    McCormack DG, Barnes PJ, Evans TW.
    Clin Sci (Lond); 1989 Oct 20; 77(4):439-43. PubMed ID: 2805602
    [Abstract] [Full Text] [Related]

  • 73.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 74. Platelet-activating factor antagonist, BN-52021 protects against cis-diamminedichloroplatinum nephrotoxicity in the rat.
    Pirotzky E, Guilmard C, Sidoti C, Ivanow F, Principe P, Braquet P.
    Ren Fail; 1990 Oct 20; 12(3):171-6. PubMed ID: 2287769
    [Abstract] [Full Text] [Related]

  • 75. Evidence for a role of platelet activating factor in the pathogenesis of irreversible but not reversible myocardial injury after reperfusion in dogs.
    Maruyama M, Farber NE, Vercellotti GM, Jacob HS, Gross GJ.
    Am Heart J; 1990 Sep 20; 120(3):510-20. PubMed ID: 2389687
    [Abstract] [Full Text] [Related]

  • 76. Role of paf-acether in the mediation of pathophysiological responses to aggregated immunoglobulins. Studies with the platelet-activating factor receptor antagonist BN 52021.
    Fernandez-Gallardo S, Cano E, Braquet P, Sanchez Crespo M.
    Int J Immunopharmacol; 1988 Sep 20; 10(4):353-60. PubMed ID: 3139574
    [Abstract] [Full Text] [Related]

  • 77. Effect of a platelet-activating factor antagonist and desferrioxamine administration on eicosanoid production in rat pancreas transplantation.
    Pi F, Hotter G, Closa D, Roselló-Catafau J, Bulbena O, Badosa F, Morris M, Fernández-Cruz L, Gelpi E.
    Transplantation; 1994 Jan 20; 57(1):12-7. PubMed ID: 8291097
    [Abstract] [Full Text] [Related]

  • 78.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 79. Involvement of platelet-activating factor (PAF) in glutamate neurotoxicity in rat neuronal cultures.
    Nogami K, Hirashima Y, Endo S, Takaku A.
    Brain Res; 1997 Apr 18; 754(1-2):72-8. PubMed ID: 9134961
    [Abstract] [Full Text] [Related]

  • 80. Platelet-activating factor: an endogenous mediator of mesenteric ischemia-reperfusion-induced shock.
    Mózes T, Braquet P, Filep J.
    Am J Physiol; 1989 Oct 18; 257(4 Pt 2):R872-7. PubMed ID: 2802004
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 14.